400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR-INR-16008740
正在进行
/
/
/
2016-06-27
/
/
心臟手術
利用血栓彈力圖來引導輸注血液製品對心臟手術後的出血量及血液製品使用量之影響
利用血栓彈力圖來引導輸注血液製品對心臟手術後的出血量及血液製品使用量之影響
利用血栓彈力圖來引導輸注血液製品對心臟手術後的出血量及血液製品使用量之影響
随机平行对照
治疗新技术
Computer-generated, sealed-envelop
/
N/A
/
/
/
1990-01-01
1990-01-01
/
Patients undergoing single or multiple valve replacement with or without CABG; all subjects required cardiopulmonary bypass. All study subjects should be capable to provide informed consent.;
请登录查看Haemodynamically unstable requiring inotropes and intra-aortic balloon pump, Active malignancy, Bleeding diathesis, preexsisiting platelet count <100 x10^9/L or INR <1.5, Use of low molecular weight heparin within 4 hours, Use of warfarin within 72 hours, Use of aspirin >325mg per day, Use of clopidogrel within 5 days, Recent treatment with glycoprotein IIbIIIa antagonist within 5days, Liver disease with raised liver enzyme, Renal dysfunction Cr >2mg/dL or>177 mmol/L, Resternotomy case.;
请登录查看Prince of Wales Hospital
/
基石药业官微2026-02-16
一度医药2026-02-16
药明康德2026-02-16
医麦客2026-02-16
良医汇肿瘤资讯2026-02-15
国际眼科时讯2026-02-15
医麦客2026-02-15
药时空2026-02-15
石药集团2026-02-14
江苏康宁杰瑞生物制药有限公司2026-02-14